B42.1
Lymphocutaneous sporotrichosis
Clinical Classification Guidelines
Medical Intelligence & Overview
Lymphocutaneous sporotrichosis is a type of fungal infection caused by the fungus Sporothrix schenckii. This infection primarily affects the skin and lymphatic system. It typically results from the bacteria entering the skin through minor cuts or abrasions, leading to localized skin lesions that can spread along lymphatic channels. Recognized under ICD-10 code B42.1, this condition is more common among outdoor workers, gardeners, and those in contact with plant material or soil. Proper awareness is important for early recognition and management.
Causes & Symptoms
Clinical Causes: Inoculation of Sporothrix schenckii fungus into the skin through punctures or cuts, often from handling soil, plants, or organic matter. Trauma involving plant material, such as thorns, roses, or wood splinters. Occupational exposure, particularly among farmers, gardeners, or landscapers. Rarely, transmission from person to person or through contaminated objects.
Key Symptoms: Initial skin lesion: firm, painless, ulcerated nodule at the site of entry. Lymphatic spread: multiple nodules or ulcers developing along the lymphatic channels proximal to the initial lesion, often with a tender, cord-like appearance. Swelling and redness of the affected lymph nodes. Possible regional lymphadenitis with tenderness. In some cases, lesions may become ulcerative or suppurative. Localized or systemic symptoms like mild fever or malaise are uncommon.
Diagnostic & Treatment
Diagnosis Path: Clinical evaluation: identification of characteristic skin lesions and lymphatic streaks. Laboratory tests: culture of the lesion tissue to identify Sporothrix schenckii fungus. Histopathological examination: skin biopsy showing fungal elements within tissue. Molecular diagnostics: PCR testing may assist in identification in uncertain cases. Serological tests are generally less specific but may support diagnosis.
Treatment Protocols: Antifungal medications: the primary treatment involves oral antifungals such as itraconazole, typically administered over several months. Potassium iodide: an older therapy option that can be effective in some cases. Local measures: wound care and proper hygiene to prevent secondary infections. Referral to infectious disease specialists is recommended for complicated or resistant cases.
Clinical Advice & FAQs
Billing Guidance
Is B42.1 a billable ICD-10 code?
Yes, B42.1 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report B42.1?
Clinical documentation must specify the nature of Lymphocutaneous sporotrichosis and any associated comorbidities for accurate reporting.
Cite this Clinical Reference
